Thomas Linn

Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting beta-cells.

Rüdiger Göke, H. C. Fehmann, Thomas Linn et al. · Journal of Biological Chemistry · 1993 · 838 citations · Full text

Life Sciences, Endocrinology, Pharmacology +17

The Pattern Recognition Receptor (RAGE) Is a Counterreceptor for Leukocyte Integrins

Triantafyllos Chavakis, Angelika Bierhaus, Nadia Al‐Fakhri et al. · The Journal of Experimental Medicine · 2003 · 576 citations · Full text

Life Sciences, Cell Biology, Immunology +17

Once-daily basal insulin glargine versus thrice-daily prandial insulin lispro in people with type 2 diabetes on oral hypoglycaemic agents (APOLLO): an open randomised controlled trial

Reinhard G. Bretzel, Ulrike A. Nuber, Wolfgang Landgraf et al. · The Lancet · 2008 · 305 citations

Medicine, Pharmacology, Pharmacotherapy +15

Effect of long-term dietary protein intake on glucose metabolism in humans

Thomas Linn, Budi Santosa, Dietrich Grönemeyer et al. · Diabetologia · 2000 · 246 citations · Full text

Life Sciences, Nutrition, Nutritional Sciences +12

Uptake and Transport of PEG-Graft-Trimethyl-Chitosan Copolymer–Insulin Nanocomplexes by Epithelial Cells

Shirui Mao, Oliver Germershaus, Dagmar Fischer et al. · Pharmaceutical Research · 2005 · 161 citations

Pharmacy, Biomedical Engineering, Molecular Pharmaceutics +13